Chemours Q3 Adj EPS $0.63 Misses $0.69 Estimate, Sales $1.49B Miss $1.514B Estimate
Portfolio Pulse from Benzinga Newsdesk
Chemours (NYSE:CC) reported Q3 earnings of $0.63 per share, missing the analyst consensus estimate of $0.72 by 12.5%. This is a 49.19% decrease from the same period last year. The company also reported quarterly sales of $1.49 billion, missing the analyst consensus estimate of $1.53 billion by 2.81%. This is a 16.32% decrease from the same period last year.

October 26, 2023 | 8:42 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Chemours' Q3 earnings and sales missed estimates, with a significant decrease from the same period last year. This could negatively impact the company's stock price in the short term.
Chemours' Q3 earnings and sales fell short of analyst estimates, and also showed a significant decrease from the same period last year. This underperformance could lead to a decrease in investor confidence, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100